These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Complex compounds of plasminogen with heparin (PGH) and plasmin with heparin (PH) and their importance in regulating the liquid state of the blood]. Kudriashov BA; Liapina LA Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):28-30. PubMed ID: 4282511 [No Abstract] [Full Text] [Related]
24. A new approach to studies of the fibrinolytic enzyme system in man. Cash JD Am Heart J; 1968 Mar; 75(3):424-8. PubMed ID: 4230185 [No Abstract] [Full Text] [Related]
27. The inhibitory effect of protoporphyrin on the fibrinolytic system in vitro. Suyama T; Iga Y; Kawano T Biochim Biophys Acta; 1966 Sep; 127(1):258-60. PubMed ID: 4226327 [No Abstract] [Full Text] [Related]
28. Intrapericardial streptokinase fibrinolysis in the management of purulent pneumococcal pericarditis. Maynar J; Corral E; Manzano A; Fonseca F; Ulibarrena MA; Cantabrana S; Labayen F Intensive Care Med; 1997 Aug; 23(8):925-6. PubMed ID: 9310820 [No Abstract] [Full Text] [Related]
30. [Fibrinolysis in the pathology of the eye. I. Preliminary note]. Giacomazzi G Haematologica; 1967; 52(9):723-31. PubMed ID: 4238249 [No Abstract] [Full Text] [Related]
31. Bacterial metastasis: the host plasminogen system in bacterial invasion. Lähteenmäki K; Edelman S; Korhonen TK Trends Microbiol; 2005 Feb; 13(2):79-85. PubMed ID: 15680767 [TBL] [Abstract][Full Text] [Related]
32. [Thrombolysis therapy, its use and dosage. I. Theoretical considerations]. Bosseckert H Z Arztl Fortbild (Jena); 1966 Jul; 60(13):777-81. PubMed ID: 4231080 [No Abstract] [Full Text] [Related]
33. Vascular injury: its effect on thrombolysis. Silver D J Trauma; 1969 Aug; 9(8):668-74. PubMed ID: 4240449 [No Abstract] [Full Text] [Related]
34. [Intact leukocyte release of fibrinolysis activators and inhibitors in chronic myeloleukemia and in healthy persons]. Krasik IaD Probl Gematol Pereliv Krovi; 1978 Sep; 23(9):30-3. PubMed ID: 151858 [No Abstract] [Full Text] [Related]
35. [Fibrinolytic therapy of patients with pulmonary artery thromboembolism by tissue plasminogen activator and streptokinase preparations]. Ardashev VN; Sokolianskiĭ NV; Bystrov VV Klin Med (Mosk); 2000; 78(12):28-30. PubMed ID: 11210347 [TBL] [Abstract][Full Text] [Related]
36. [Humoral factors of the anticoagulative system]. Kudrjashov BA Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):391-6. PubMed ID: 4121332 [No Abstract] [Full Text] [Related]
37. [Fibrinolysis and liver regeneration]. Seki T; Uno S; Ariga T Seikagaku; 1999 May; 71(5):350-3. PubMed ID: 10391987 [No Abstract] [Full Text] [Related]
38. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Sun H; Ringdahl U; Homeister JW; Fay WP; Engleberg NC; Yang AY; Rozek LS; Wang X; Sjöbring U; Ginsburg D Science; 2004 Aug; 305(5688):1283-6. PubMed ID: 15333838 [TBL] [Abstract][Full Text] [Related]
39. A trial of intrapleural streptokinase. Katikireddy CK; Dube DS N Engl J Med; 2005 May; 352(21):2243-5; author reply 2243-5. PubMed ID: 15917392 [No Abstract] [Full Text] [Related]
40. [Role of fibrinolytic enzymes in corneal ulceration]. Beznos OV; Chesnokova NB Vestn Oftalmol; 1999; 115(4):42-4. PubMed ID: 10523971 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]